中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
4期
44-46
,共3页
早发型子痫前期%硫酸镁%低分子量肝素%丹参
早髮型子癇前期%硫痠鎂%低分子量肝素%丹參
조발형자간전기%류산미%저분자량간소%단삼
Early onset preeclampsia%Magnesium sulfate%Low molecular weight heparin%Salvia miltiorrhiza
目的：探讨不同治疗方法对早发型子痫前期的临床疗效。方法：抽取来本院就诊的96例发型子痫前期孕妇，随机分为三组，硫酸镁组、硫酸镁+LMWH组、硫酸镁+LMWH+SM组，每组各32例。通过观察三组妊娠结局、血压变化、APTT值、新生儿情况等来判断三组的临床疗效。结果：三组患者血压、APTT值的治疗前后比较，差异均有统计学意义（P<0.05）；硫酸组的新生儿窒息发生率最高达62.5%，存活率最低只有87.5%，与其他两组比较差异均有统计学意义（P<0.05）。三组患者的治疗时间及新生儿体重两两比较，均无明显差异。结论：硫酸镁+低分子肝素+丹参联合治疗早发型子痫前期效果最佳，值得临床推广应用。
目的：探討不同治療方法對早髮型子癇前期的臨床療效。方法：抽取來本院就診的96例髮型子癇前期孕婦，隨機分為三組，硫痠鎂組、硫痠鎂+LMWH組、硫痠鎂+LMWH+SM組，每組各32例。通過觀察三組妊娠結跼、血壓變化、APTT值、新生兒情況等來判斷三組的臨床療效。結果：三組患者血壓、APTT值的治療前後比較，差異均有統計學意義（P<0.05）；硫痠組的新生兒窒息髮生率最高達62.5%，存活率最低隻有87.5%，與其他兩組比較差異均有統計學意義（P<0.05）。三組患者的治療時間及新生兒體重兩兩比較，均無明顯差異。結論：硫痠鎂+低分子肝素+丹參聯閤治療早髮型子癇前期效果最佳，值得臨床推廣應用。
목적：탐토불동치료방법대조발형자간전기적림상료효。방법：추취래본원취진적96례발형자간전기잉부，수궤분위삼조，류산미조、류산미+LMWH조、류산미+LMWH+SM조，매조각32례。통과관찰삼조임신결국、혈압변화、APTT치、신생인정황등래판단삼조적림상료효。결과：삼조환자혈압、APTT치적치료전후비교，차이균유통계학의의（P<0.05）；류산조적신생인질식발생솔최고체62.5%，존활솔최저지유87.5%，여기타량조비교차이균유통계학의의（P<0.05）。삼조환자적치료시간급신생인체중량량비교，균무명현차이。결론：류산미+저분자간소+단삼연합치료조발형자간전기효과최가，치득림상추엄응용。
Objective:To investigate the clinical efficacy of different treatment methods on early onset preeclampsia.Method:96 cases of early pregnant women in the sampled in our hospital,were randomly divided into three groups,the group of magnesium sulfate,magnesium sulfate and low molecular heparin group(magnesium sulfate+LMWH group),magnesium sulfate+low molecular weight heparin+Salvia miltiorrhiza group(magnesium sulfate+LMWH+SM group),32 cases in each group.Through the observation of pregnancy outcome,the changes of blood pressure,APTT value,newborn and to determine the clinical effects of the three groups.Result:Three groups of patients with blood pressure and APTT value were compared before and after treatment,the differences were statistically significant(P<0.05);magnesium sulfate group of neonatal asphyxia incidence was highest of 62.5%and the neonatal survival rate was the lowest of 87.5%,compared with other two groups had significant difference(P<0.05).Three groups of patients with treatment time and neonatal weight were compared,there were no significant differences.Conclusion:Magnesium sulfate+low molecular weight heparin+salvia miltiorrhiza combined treatment of early onset preeclampsia have best effect,worthy of clinical application.
